HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin G avidity in the serodiagnosis of congenital rubella syndrome.

Abstract
The avidity of specific IgG was investigated in three infants with serologically verified congenital rubella infection. Two sera were taken from each infant: the first soon after birth and the second at the age of 23 to 31 months. Avidity of specific IgG was measured by a protein-denaturing enzyme immunoassay using urea as the elution factor, and avidity then determined by the end-point ratio (derived from antibody titration) and the avidity index methods. Rubella-specific IgM was present in the first sera of all patients, but not in the second sera. However, low avidity of specific IgG persisted in two children until age 23 to 31 months, as determined by the end-point ratio method. These data are in agreement with the findings of previous studies of avidity in congenital rubella, and show the usefulness of the protein-denaturing IgG-avidity assays employing the end-point ratio method for serological diagnosis of congenital rubella even after disappearance of specific IgM.
AuthorsV Herne, K Hedman, P Reedik
JournalEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis) Vol. 16 Issue 10 Pg. 763-6 (Oct 1997) ISSN: 0934-9723 [Print] Germany
PMID9405951 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M
  • Urea
Topics
  • Antibodies, Viral (immunology)
  • Antibody Affinity
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Immunoglobulin G (immunology)
  • Immunoglobulin M (immunology)
  • Immunologic Tests (methods)
  • Infant
  • Infant, Newborn
  • Pregnancy
  • Rubella Syndrome, Congenital (diagnosis, immunology)
  • Urea (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: